200
Participants
Start Date
November 22, 2017
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
the radiotracer 18F-AV-1451
Subjects will receive a single IV bolus injection target dose of approximately 370 MBq (10 mCi ± 20%) of 18F-AV-1451 At approximately 75 minutes post dose, scanning will begin. An approximately 30-minute acquisition (six 5 minute intervals) will be performed
RECRUITING
UPenn, Philadelphia
National Institutes of Health (NIH)
NIH
National Institute on Aging (NIA)
NIH
University of Pennsylvania
OTHER